Clinical Trial Update: This is an Open-label, Non-randomized Study to Assess the Pharmacokinetics (PK) of VCT220 in Healthy Volunteers When Administered With Rifampin or Itraconazole [Phase 1]

View source ↗

Summary

This open-label, non-randomized Phase 1 study evaluates the pharmacokinetics of VCT220 in healthy volunteers when co-administered with rifampin or itraconazole;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Itraconazole (Itraconazole)
• RIFAMPIN (RIFAMPIN)
• VCT220

Snippet

Sponsor: Vincentage Pharma Co., Ltd | Conditions: Obesity &Amp; Overweight | Phase 1 | Status: COMPLETED